A Study of Facial Nerve Monitoring During Surgical Removal of the Parotid Gland for Superficial Benign Lesions

Overview

About this study

The purpose of this study is to determine the benefit to postoperative facial nerve function of using electromyography (EMG) based monitoring of facial nerve function during surgery to remove the parotid gland for superficial benign lesions.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

≥ 18 years
Treated at Mayo Clinic for primary, benign parotid lesions using superficial parotidectomy

Exclusion Criteria

Revision operations
Prior head and neck radiation
Prior head and neck surgery
Malignant parotid lesions
Patients taking steroids
Patients with diabetes
Pregnant patients
- A pregnancy test will be included in the pre-operative workup of all females of childbearing potential enrolled in the study
Patients with preoperative facial nerve dysfunction

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Jeffrey Janus, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Janus, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials